The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients
In a double-blind, placebo-controlled cross-over study, the plasma atrial natriuretic peptide (ANP) levels of nine young and ten elderly hypertensive patients were compared after placebo and after treatment with 120 mg verapamil given three times daily over 4 weeks. During placebo, plasma ANP levels...
Gespeichert in:
| Veröffentlicht in: | European journal of clinical pharmacology 1990-01, Vol.39 (1), p.S39-S40 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S40 |
|---|---|
| container_issue | 1 |
| container_start_page | S39 |
| container_title | European journal of clinical pharmacology |
| container_volume | 39 |
| creator | VAN BORTEL, L. M. A. B SCHIFFERS, P. M. H BÖHM, R. O. B MOOIJ, J. M. V RAHN, K. H STRUYKER-BOUDIER, H. A. J |
| description | In a double-blind, placebo-controlled cross-over study, the plasma atrial natriuretic peptide (ANP) levels of nine young and ten elderly hypertensive patients were compared after placebo and after treatment with 120 mg verapamil given three times daily over 4 weeks. During placebo, plasma ANP levels proved to be higher in elderly patients than in young subjects. Chronic treatment with verapamil induced a rise in ANP levels in both young and elderly patients with hypertension. |
| doi_str_mv | 10.1007/BF01409206 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80186505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80186505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-db9631797133ea2dbfe704662f08e3866157660fdc5d565aee2ad8616b2f6b243</originalsourceid><addsrcrecordid>eNpFkEFv1DAQRi0EKkvhwh3JFzggBWbsxEmOtKKAVIlLOUezzpg1cpxgO4v2zg8nVVf0MPoO8-aN9AnxGuEDArQfr24Aa-gVmCdih7VWFUKNT8UOQGNl-haeixc5_wLApgd9IS4U1h02sBN_7w4sfXRh5WhZzk7aQ5qjt7IkpjJxLPKPLwd55EQLTT7IOcolUJ5IUkmegoz3uSYu29XCS_Ejy8BHDnkzy9O8xp-Sw8gpnOThtHAqHLM_slyo-O1BfimeOQqZX53zUvy4-Xx3_bW6_f7l2_Wn28pqVKUa973R2PYtas2kxr3jFmpjlIOOdWcMNq0x4EbbjI1piFnR2Bk0e-W2qfWlePfgXdL8e-VchslnyyFQ5HnNQwfYmQaaDXz_ANo055zYDUvyE6XTgDDcVz48Vr7Bb87WdT_x-B89d7zt3573lC0Flyhanx-NfQ2q61r9D4fyisQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80186505</pqid></control><display><type>article</type><title>The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>VAN BORTEL, L. M. A. B ; SCHIFFERS, P. M. H ; BÖHM, R. O. B ; MOOIJ, J. M. V ; RAHN, K. H ; STRUYKER-BOUDIER, H. A. J</creator><creatorcontrib>VAN BORTEL, L. M. A. B ; SCHIFFERS, P. M. H ; BÖHM, R. O. B ; MOOIJ, J. M. V ; RAHN, K. H ; STRUYKER-BOUDIER, H. A. J</creatorcontrib><description>In a double-blind, placebo-controlled cross-over study, the plasma atrial natriuretic peptide (ANP) levels of nine young and ten elderly hypertensive patients were compared after placebo and after treatment with 120 mg verapamil given three times daily over 4 weeks. During placebo, plasma ANP levels proved to be higher in elderly patients than in young subjects. Chronic treatment with verapamil induced a rise in ANP levels in both young and elderly patients with hypertension.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/BF01409206</identifier><identifier>PMID: 2148150</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Aged ; Antihypertensive agents ; Atrial Natriuretic Factor - blood ; Biological and medical sciences ; Blood Pressure - drug effects ; Cardiovascular system ; Double-Blind Method ; Humans ; Hypertension - blood ; Hypertension - drug therapy ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Time Factors ; Verapamil - administration & dosage ; Verapamil - therapeutic use</subject><ispartof>European journal of clinical pharmacology, 1990-01, Vol.39 (1), p.S39-S40</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-db9631797133ea2dbfe704662f08e3866157660fdc5d565aee2ad8616b2f6b243</citedby><cites>FETCH-LOGICAL-c312t-db9631797133ea2dbfe704662f08e3866157660fdc5d565aee2ad8616b2f6b243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19402887$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2148150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN BORTEL, L. M. A. B</creatorcontrib><creatorcontrib>SCHIFFERS, P. M. H</creatorcontrib><creatorcontrib>BÖHM, R. O. B</creatorcontrib><creatorcontrib>MOOIJ, J. M. V</creatorcontrib><creatorcontrib>RAHN, K. H</creatorcontrib><creatorcontrib>STRUYKER-BOUDIER, H. A. J</creatorcontrib><title>The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>In a double-blind, placebo-controlled cross-over study, the plasma atrial natriuretic peptide (ANP) levels of nine young and ten elderly hypertensive patients were compared after placebo and after treatment with 120 mg verapamil given three times daily over 4 weeks. During placebo, plasma ANP levels proved to be higher in elderly patients than in young subjects. Chronic treatment with verapamil induced a rise in ANP levels in both young and elderly patients with hypertension.</description><subject>Adult</subject><subject>Aged</subject><subject>Antihypertensive agents</subject><subject>Atrial Natriuretic Factor - blood</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular system</subject><subject>Double-Blind Method</subject><subject>Humans</subject><subject>Hypertension - blood</subject><subject>Hypertension - drug therapy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><subject>Verapamil - administration & dosage</subject><subject>Verapamil - therapeutic use</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFv1DAQRi0EKkvhwh3JFzggBWbsxEmOtKKAVIlLOUezzpg1cpxgO4v2zg8nVVf0MPoO8-aN9AnxGuEDArQfr24Aa-gVmCdih7VWFUKNT8UOQGNl-haeixc5_wLApgd9IS4U1h02sBN_7w4sfXRh5WhZzk7aQ5qjt7IkpjJxLPKPLwd55EQLTT7IOcolUJ5IUkmegoz3uSYu29XCS_Ejy8BHDnkzy9O8xp-Sw8gpnOThtHAqHLM_slyo-O1BfimeOQqZX53zUvy4-Xx3_bW6_f7l2_Wn28pqVKUa973R2PYtas2kxr3jFmpjlIOOdWcMNq0x4EbbjI1piFnR2Bk0e-W2qfWlePfgXdL8e-VchslnyyFQ5HnNQwfYmQaaDXz_ANo055zYDUvyE6XTgDDcVz48Vr7Bb87WdT_x-B89d7zt3573lC0Flyhanx-NfQ2q61r9D4fyisQ</recordid><startdate>19900101</startdate><enddate>19900101</enddate><creator>VAN BORTEL, L. M. A. B</creator><creator>SCHIFFERS, P. M. H</creator><creator>BÖHM, R. O. B</creator><creator>MOOIJ, J. M. V</creator><creator>RAHN, K. H</creator><creator>STRUYKER-BOUDIER, H. A. J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900101</creationdate><title>The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients</title><author>VAN BORTEL, L. M. A. B ; SCHIFFERS, P. M. H ; BÖHM, R. O. B ; MOOIJ, J. M. V ; RAHN, K. H ; STRUYKER-BOUDIER, H. A. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-db9631797133ea2dbfe704662f08e3866157660fdc5d565aee2ad8616b2f6b243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antihypertensive agents</topic><topic>Atrial Natriuretic Factor - blood</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular system</topic><topic>Double-Blind Method</topic><topic>Humans</topic><topic>Hypertension - blood</topic><topic>Hypertension - drug therapy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><topic>Verapamil - administration & dosage</topic><topic>Verapamil - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN BORTEL, L. M. A. B</creatorcontrib><creatorcontrib>SCHIFFERS, P. M. H</creatorcontrib><creatorcontrib>BÖHM, R. O. B</creatorcontrib><creatorcontrib>MOOIJ, J. M. V</creatorcontrib><creatorcontrib>RAHN, K. H</creatorcontrib><creatorcontrib>STRUYKER-BOUDIER, H. A. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN BORTEL, L. M. A. B</au><au>SCHIFFERS, P. M. H</au><au>BÖHM, R. O. B</au><au>MOOIJ, J. M. V</au><au>RAHN, K. H</au><au>STRUYKER-BOUDIER, H. A. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>1990-01-01</date><risdate>1990</risdate><volume>39</volume><issue>1</issue><spage>S39</spage><epage>S40</epage><pages>S39-S40</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>In a double-blind, placebo-controlled cross-over study, the plasma atrial natriuretic peptide (ANP) levels of nine young and ten elderly hypertensive patients were compared after placebo and after treatment with 120 mg verapamil given three times daily over 4 weeks. During placebo, plasma ANP levels proved to be higher in elderly patients than in young subjects. Chronic treatment with verapamil induced a rise in ANP levels in both young and elderly patients with hypertension.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>2148150</pmid><doi>10.1007/BF01409206</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-6970 |
| ispartof | European journal of clinical pharmacology, 1990-01, Vol.39 (1), p.S39-S40 |
| issn | 0031-6970 1432-1041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80186505 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adult Aged Antihypertensive agents Atrial Natriuretic Factor - blood Biological and medical sciences Blood Pressure - drug effects Cardiovascular system Double-Blind Method Humans Hypertension - blood Hypertension - drug therapy Medical sciences Middle Aged Pharmacology. Drug treatments Time Factors Verapamil - administration & dosage Verapamil - therapeutic use |
| title | The influence of chronic treatment with verapamil on plasma atrial natriuretic peptide levels in young elderly hypertensive patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T19%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20chronic%20treatment%20with%20verapamil%20on%20plasma%20atrial%20natriuretic%20peptide%20levels%20in%20young%20elderly%20hypertensive%20patients&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=VAN%20BORTEL,%20L.%20M.%20A.%20B&rft.date=1990-01-01&rft.volume=39&rft.issue=1&rft.spage=S39&rft.epage=S40&rft.pages=S39-S40&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/BF01409206&rft_dat=%3Cproquest_cross%3E80186505%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80186505&rft_id=info:pmid/2148150&rfr_iscdi=true |